• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞(颞)动脉炎与高安动脉炎的临床鉴别

Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis.

作者信息

Michel B A, Arend W P, Hunder G G

机构信息

Clinic of Rheumatology, University Hospital, Zürich, Switzerland.

出版信息

J Rheumatol. 1996 Jan;23(1):106-11.

PMID:8838517
Abstract

OBJECTIVE

To determine whether giant cell (temporal) arteritis (GCA) can be differentiated from Takayasu's arteritis on the basis of clinical findings.

METHODS

A comparative study contrasting 217 patients with GCA to 63 patients with Takayasu's arteritis was conducted, using the prospectively gathered large multicenter data set of the American College of Rheumatology Vasculitis Criteria Databank. Logistic regression and recursive partitioning were used to assess the capability of a variety of variables to separate these 2 vasculitic disorders.

RESULTS

Age of 40 years at onset of disease was the most discriminatory single variable. Excluding age at onset, ethnic background and a combination of clinical signs indicating upper limb vascular impairment, shoulder stiffness, and tender scalp led to correct classifications of 95% in both GCA and Takayasu's arteritis. Vascular insufficiency of the upper extremities, a key feature of Takayasu's arteritis, was noted in 15% of patients with GCA, although to a lesser degree.

CONCLUSION

Although similar in many respects, GCA and Takayasu's arteritis were easily definable and separable disorders, even when the typical age barrier of 40 years at onset of disease was excluded. These findings strengthen the concept that they are distinct disease entities.

摘要

目的

基于临床发现确定巨细胞(颞)动脉炎(GCA)是否可与大动脉炎相鉴别。

方法

利用美国风湿病学会血管炎标准数据库前瞻性收集的大型多中心数据集,对217例GCA患者和63例大动脉炎患者进行了一项对比研究。采用逻辑回归和递归划分法评估多种变量区分这两种血管炎疾病的能力。

结果

发病年龄40岁是最具鉴别性的单一变量。排除发病年龄后,种族背景以及提示上肢血管损害、肩部僵硬和头皮压痛的临床体征组合,在GCA和大动脉炎中均能实现95%的正确分类。大动脉炎的关键特征——上肢血管功能不全,在15%的GCA患者中也有发现,尽管程度较轻。

结论

尽管GCA和大动脉炎在许多方面相似,但即使排除发病年龄40岁这一典型界限,它们仍是易于定义和区分的疾病。这些发现强化了它们是不同疾病实体的概念。

相似文献

1
Clinical differentiation between giant cell (temporal) arteritis and Takayasu's arteritis.巨细胞(颞)动脉炎与高安动脉炎的临床鉴别
J Rheumatol. 1996 Jan;23(1):106-11.
2
Takayasu's disease and temporal arteritis.高安氏病和颞动脉炎。
Semin Vasc Surg. 1995 Dec;8(4):335-41.
3
Takayasu's arteritis in a 69 year-old woman.
Intern Med. 2000 Jan;39(1):69-72. doi: 10.2169/internalmedicine.39.69.
4
[Large-vessel vasculitides].[大血管血管炎]
Duodecim. 2011;127(15):1539-47.
5
What is the best approach to diagnosing large-vessel vasculitis?诊断大血管血管炎的最佳方法是什么?
Best Pract Res Clin Rheumatol. 2005 Apr;19(2):223-42. doi: 10.1016/j.berh.2005.01.006.
6
[Epidemiology and etiological factors in giant cell arteritis (Horton's disease and Takayasu's disease)].[巨细胞动脉炎(霍顿病和高安病)的流行病学及病因学因素]
Ann Med Interne (Paris). 1998 Nov;149(7):425-32.
7
Takayasu's arteritis.高安动脉炎
J Am Osteopath Assoc. 1989 Jan;89(1):90-4.
8
[Giant cell arteritis and polymyalgia rheumatica presenting as subclavian artery obstruction].以锁骨下动脉梗阻为表现的巨细胞动脉炎和风湿性多肌痛
Ryumachi. 1993 Aug;33(4):330-4.
9
Takayasu's arteritis: A study of 104 Italian patients.高安动脉炎:对104例意大利患者的研究。
Arthritis Rheum. 2005 Feb 15;53(1):100-7. doi: 10.1002/art.20922.
10
[Clinical features and treatment of giant cell arteritis in Chinese, a prospective study].[巨细胞动脉炎的临床特征与治疗(中文),一项前瞻性研究]
Zhonghua Yi Xue Za Zhi. 2002 Apr 10;82(7):453-5.

引用本文的文献

1
Ischemic stroke or transient ischemic attack due to cervical and intracranial large-vessel vasculitis secondary to primary Sjögren's syndrome: A case series and literature review.原发性干燥综合征继发颈内及颅内大血管血管炎所致缺血性脑卒中或短暂性脑缺血发作:病例系列及文献综述
Heliyon. 2024 Jul 6;10(14):e34225. doi: 10.1016/j.heliyon.2024.e34225. eCollection 2024 Jul 30.
2
[Diagnostics and treatment of large vessel vasculitis].[大血管血管炎的诊断与治疗]
Inn Med (Heidelb). 2024 Feb;65(2):107-113. doi: 10.1007/s00108-023-01656-1. Epub 2024 Jan 19.
3
Primary Systemic Vasculitides as a Cause of Group IV Pulmonary Hypertension.
原发性系统性血管炎导致的 IV 型肺动脉高压。
Anatol J Cardiol. 2023 Dec 1;27(12):677-687. doi: 10.14744/AnatolJCardiol.2023.3650. Epub 2023 Nov 21.
4
Isolated Abdominal Aortitis Following a Urinary Tract Infection.尿路感染后孤立性腹主动脉炎
Cureus. 2021 Oct 19;13(10):e18902. doi: 10.7759/cureus.18902. eCollection 2021 Oct.
5
Coronary Vasculitis.冠状动脉血管炎
Biomedicines. 2021 May 31;9(6):622. doi: 10.3390/biomedicines9060622.
6
Mechanism and biomarkers in aortitis--a review.巨细胞动脉炎的发病机制和生物标志物——综述。
J Mol Med (Berl). 2020 Jan;98(1):11-23. doi: 10.1007/s00109-019-01838-1. Epub 2019 Oct 30.
7
Inflammatory and infectious aortic diseases.炎症性和感染性主动脉疾病。
Cardiovasc Diagn Ther. 2018 Apr;8(Suppl 1):S61-S70. doi: 10.21037/cdt.2017.09.03.
8
Fewer subsequent relapses and lower levels of IL-17 in Takayasu arteritis developed after the age of 40 years.40岁以后发病的大动脉炎患者,后续复发次数较少,白细胞介素-17水平较低。
Arthritis Res Ther. 2016 Dec 13;18(1):293. doi: 10.1186/s13075-016-1193-9.
9
Chest Pain: The Need to Consider Less Frequent Diagnosis.胸痛:需考虑不常见的诊断
Case Rep Cardiol. 2016;2016:4294780. doi: 10.1155/2016/4294780. Epub 2016 Feb 29.
10
Malignancy risk in vasculitis.血管炎的恶性肿瘤风险。
Ther Adv Musculoskelet Dis. 2011 Feb;3(1):55-63. doi: 10.1177/1759720X10387460.